We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA To Review Approval Of Norvasc Generic As 505 (b) (2) Gateway Is Tested In Court

Law360 (February 9, 2004, 12:00 AM EST) -- In a move that could have broad ramifications for 505 (b) (2) generic drug approvals, the U.S. Food and Drug Administration has stayed its decision to allow Indian drug maker Dr....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.